Ablynx Ups Profile Stateside With $200m Nasdaq Listing

 
• By Kevin Grogan

Success in the clinic with caplacizumab for aTTP and a big IPO in the USA has put the Belgium-headquartered group in the spotlight.

Dollar Airplane_1200
Flying high: Ablynx IPO in the US has been a success • Source: Shutterstock

More from Business

More from Scrip